FIELD: medicine. SUBSTANCE: innovation deals with the methods to suppress excessive output of alpha and interleukin-1 beta tumor necrosis factor and, also, treat diseases as a result of excessive synthesis of these cytokines, Alzheimer's and Parkinson's diseases by using derived indolcarbazole K-252A. EFFECT: higher efficiency of therapy. 8 cl, 10 ex, 4 tbl, 5 dwg
Authors
Dates
2002-06-27—Published
1997-06-24—Filed